肤痔清软膏联合氯雷他定片治疗慢性肛周湿疹临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R758.23

基金项目:

浙江省医药卫生科技计划项目(2018KY930)


Clinical Study on Fuzhiqing Ointment Combined with Loratadine Tablets for Chronic Perianal Eczema
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察肤痔清软膏联合口服氯雷他定片治疗慢性肛周湿疹的临床疗效。方法:选取102 例慢性肛周湿疹患者,按随机数字表法分为治疗组52 例与对照组50 例。对照组给予单纯氯雷他定片口服治疗,治疗组在对照组基础上给予肤痔清软膏外敷治疗。2 组均治疗2 周。比较2 组临床疗效及随访3 个月、6 个月复发率发生情况,比较2 组治疗前后皮损症状评分、症状消失时间、血清免疫球蛋白E(IgE) 的变化。结果:治疗组临床疗效为98.08%,对照组为86.00%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组皮损面积、皮损形态及瘙痒程度评分均较治疗前下降(P<0.05),治疗组皮损面积、皮损形态及瘙痒程度评分均低于对照组(P<0.05)。治疗后,治疗组红斑、皮疹及渗液消失时间均早于对照组,差异均有统计学意义(P<0.05)。治疗1 周、2 周后,2 组IgE 水平均较治疗前下降(P<0.05)。对2 组治疗有效患者在治疗后3 个月、6 个月进行随访,治疗组治疗后3 个月、6 个月的复发率均低于对照组(P<0.05)。结论:外敷肤痔清软膏联合口服氯雷他定片治疗慢性肛周湿疹临床疗效显著,可缓解患者临床症状,改善机体细胞免疫功能,降低复发率。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Fuzhiqing Ointment combined with Loratadine Tablets for chronic perianal eczema. Methods:A total of 102 cases of patients with chronic perianal eczema were divided into the treatment group with 52 cases and the control group with 50 cases according to the random number table method. The control group was given the oral administration of Loratadine Tablets, and the treatment group was additionally given the external application of Fuzhiqing Ointment based on the treatment of the control group. Both groups were treated for two weeks. The recurrence rates after three months and six months of follow-up as well as the clinical effects in the two groups were compared. The changes in symptom scores of skin lesions,disappearance time of symptoms and serum immunoglobulin E (IgE) before and after treatment in the two groups were compared. Results: The total effective rate of clinical effect was 98.08% in the treatment group and 86.00% in the control group, the difference being significant(P<0.05). After treatment, the scores of skin lesion area, skin lesion morphology and pruritus degree in the two groups were decreased when compared with those before treatment(P<0.05),and the scores of skin lesion area,skin lesion morphology and pruritus degree in the treatment group were lower than those in the control group(P<0.05). After treatment,the disappearance time of erythema,rash and exudate in the treatment group was earlier than that in the control group,differences being significant(P< 0.05). After one week and two weeks of treatment, IgE levels in the two groups were decreased when compared with those before treatment(P<0.05). The patients with effective treatment in the two groups were followed up in three and six months after treatment. The recurrence rates in three and six months after treatment in the treatment group were lower than those in the control group(P<0.05). Conclusion: The external application of Fuzhiqing Ointment combined with the oral administration of Loratadine Tablets for chronic perianal eczema has a significant clinical effect,and can relieve the clinical symptoms of patients, improve the cellular immune function of the body,and reduce the recurrence rate.

    参考文献
    相似文献
    引证文献
引用本文

程涛,卢吉英,滕向龙,饶志杰.肤痔清软膏联合氯雷他定片治疗慢性肛周湿疹临床研究[J].新中医,2022,54(23):134-138

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-12-11
  • 出版日期:
文章二维码